Related Experiment Videos

Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity

R P Gale, J Zighelboim

    Journal of Immunology (Baltimore, Md. : 1950)
    |March 1, 1975
    PubMed

    Insights

    Human polymorphonuclear leukocytes (PMN) efficiently lyse antibody-coated cells via antibody-dependent cellular cytotoxicity (ADCC). This rapid PMN-mediated killing mechanism, independent of complement, suggests a significant role in tumor cell immunity.

    Area of Science:

    • Immunology
    • Cell Biology
    • Cancer Research

    Background:

    • Antibody-dependent cellular cytotoxicity (ADCC) is a key immune mechanism.
    • Polymorphonuclear leukocytes (PMN) are crucial innate immune cells.
    • The role of PMN in ADCC against tumor cells requires further elucidation.

    Purpose of the Study:

    • To investigate the capacity of human PMN to mediate ADCC.
    • To characterize the kinetics and efficiency of PMN-mediated ADCC.
    • To explore the potential of PMN in anti-tumor immunity.

    Main Methods:

    • Co-incubation of human PMN with antibody-coated target cells.
    • Quantification of target cell lysis.
    • Assessment of inhibition by aggregated gamma-globulin.

    Main Results:

    • Human PMN effectively lyse antibody-coated target cells in an immunologically specific manner (ADCC).
    • PMN-mediated cytolysis is rapid, occurs at low PMN:target cell ratios, and is complement-independent.
    • The process is mediated via Fc receptors and can be inhibited by aggregated gamma-globulin.

    Conclusions:

    • Human PMN are potent mediators of ADCC against antibody-coated cells.
    • PMN-mediated ADCC is a rapid and efficient cytotoxic mechanism.
    • These findings highlight a significant role for PMN in host tumor cell immunity.

    Related Concept Videos